AU2002231500B2 - Antiangiogenic compounds and an assay for inhibitors of cell invasion - Google Patents
Antiangiogenic compounds and an assay for inhibitors of cell invasion Download PDFInfo
- Publication number
- AU2002231500B2 AU2002231500B2 AU2002231500A AU2002231500A AU2002231500B2 AU 2002231500 B2 AU2002231500 B2 AU 2002231500B2 AU 2002231500 A AU2002231500 A AU 2002231500A AU 2002231500 A AU2002231500 A AU 2002231500A AU 2002231500 B2 AU2002231500 B2 AU 2002231500B2
- Authority
- AU
- Australia
- Prior art keywords
- group
- linear
- branched
- optionally substituted
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2,332,138 | 2001-01-25 | ||
CA002332138A CA2332138A1 (en) | 2001-01-25 | 2001-01-25 | Antiangiogenic compounds and an assay for inhibitors of cell invasion |
US33067001P | 2001-10-26 | 2001-10-26 | |
US60/330,670 | 2001-10-26 | ||
PCT/CA2002/000097 WO2002058679A2 (en) | 2001-01-25 | 2002-01-25 | Antiangiogenic compounds and an assay for inhibitors of cell invasion |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002231500A1 AU2002231500A1 (en) | 2003-02-06 |
AU2002231500B2 true AU2002231500B2 (en) | 2006-04-27 |
Family
ID=25682349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002231500A Ceased AU2002231500B2 (en) | 2001-01-25 | 2002-01-25 | Antiangiogenic compounds and an assay for inhibitors of cell invasion |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1355893A2 (ja) |
JP (1) | JP2004520372A (ja) |
AU (1) | AU2002231500B2 (ja) |
WO (1) | WO2002058679A2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9266815B2 (en) | 2012-03-28 | 2016-02-23 | University Of Central Florida Research Foundation, Inc. | Anti-metastatic agents predicated upon polyamine macrocyclic conjugates |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE169930T1 (de) * | 1993-03-10 | 1998-09-15 | Magainin Pharma | Steroidderivate, pharmazeutische zusammensetzungen die sie enthalten und ihre verwendung als antibiotika oder desinfektionsmittel |
US5508188A (en) * | 1994-01-21 | 1996-04-16 | The Regents Of The University Of California | Method of growing cells in a mammal |
WO1999035283A1 (en) * | 1997-12-15 | 1999-07-15 | Beth Israel Deaconess Medical Center | Methods and reagents for modulating cell motility |
WO2000021941A1 (en) * | 1998-10-13 | 2000-04-20 | Synchem Reserach, Inc. | Biomimetic chelating agents and methods |
US6265403B1 (en) * | 1999-01-20 | 2001-07-24 | Merck & Co., Inc. | Angiogenesis inhibitors |
-
2002
- 2002-01-25 WO PCT/CA2002/000097 patent/WO2002058679A2/en not_active Application Discontinuation
- 2002-01-25 AU AU2002231500A patent/AU2002231500B2/en not_active Ceased
- 2002-01-25 EP EP02711686A patent/EP1355893A2/en not_active Withdrawn
- 2002-01-25 JP JP2002559013A patent/JP2004520372A/ja active Pending
Non-Patent Citations (1)
Title |
---|
J org Chem (1998)63(14)4838-4841,Williams et al * |
Also Published As
Publication number | Publication date |
---|---|
WO2002058679A2 (en) | 2002-08-01 |
EP1355893A2 (en) | 2003-10-29 |
WO2002058679A3 (en) | 2003-05-15 |
JP2004520372A (ja) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6689854B2 (ja) | E−セレクチンおよびcxcr4ケモカイン受容体のヘテロ二官能性阻害剤 | |
Russell et al. | Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas | |
Khwaja et al. | Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids | |
DE69912313T2 (de) | Colchinolderivate als gefässschädigende mittel | |
FI113537B (fi) | Menetelmä terapeuttisesti käyttökelpoisten indolokarbatsolijohdannaisten valmistamiseksi | |
HU225297B1 (en) | Bis staurosporin derivatives and pharmaceutical composition containing them | |
KR20150027217A (ko) | 항진균성 항생 암포테리신 b의 n-치환된 제2 세대 유도체, 및 이의 제조 및 응용 방법 | |
EP0934329A1 (de) | Glycokonjugate von modifizierten camptothecin-derivaten (20-o-verknüpfung) | |
RU2312863C2 (ru) | Тоник для роста волос | |
US6136857A (en) | Methods for treating neoplasms with betaines | |
DE3832362A1 (de) | Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung | |
AU2002231500B2 (en) | Antiangiogenic compounds and an assay for inhibitors of cell invasion | |
CZ133396A3 (en) | Anthracyclin derivatives | |
CZ22197A3 (en) | Cyclopeptides, processes of their preparation and their use for therapeutical purposes | |
US20050222126A1 (en) | Antiangiogenic compounds and an assay for inhibitors of cell invasion | |
AU2002231500A1 (en) | Antiangiogenic compounds and an assay for inhibitors of cell invasion | |
JP2761876B2 (ja) | 新規化合物、その製造方法及びその用途 | |
CA2435633A1 (en) | Antiangiogenic compounds and an assay for inhibitors of cell invasion | |
CN111943947B (zh) | 1H-吡咯[2,3-b]吡啶衍生物及其合成方法与应用 | |
DE60122350T2 (de) | Benzoesaüre derivate und deren verwendung | |
EP0289203B1 (en) | Antitumor and antiviral compounds of marine origin | |
DE69916571T2 (de) | Hemmer der angiogenese und der urokinase produktion und seine medizinische anwendung | |
CN106146612B (zh) | 一类乙二醛酶i不可逆抑制剂及其制备方法和用途 | |
JP2009503047A (ja) | 抗腫瘍性化合物 | |
KR19980013601A (ko) | 신생혈관유도현상 억제 활성을 갖는 계피 유래의 신남 알데하이드 유도체, 이의 제조방법 및 이를 함유하는 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |